Artes Medical, Inc. (ARTE) Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell


ADVISORY, March 26, 2007 (PRIME NEWSWIRE) --



 What:
 Diane Goosetree, chief executive officer of Artes Medical, Inc.
 (ARTE), will preside over the opening bell to celebrate the
 Company's recent initial public offering on NASDAQ.

 Where:
 NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio

 When:
 Tuesday, March 27, 2007 at 9:30 a.m. ET

 Contacts:
 Jenni Rosenberg/Thea Lavin
 Schwartz Communications, Inc.
 415-512-0770
 artes@schwartz-pr.com

 Cheryl Allen
 858.550.9999; callen@artesmedical.com

 NASDAQ MarketSite:
 Jolene Libretto; 646.441.5220; mobile - 347.219.9539
 Jolene.Libretto@NASDAQ.com

Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.

Radio Feed:

An audio transmission of the opening bell is also available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Waterfront fiber 1623 as well.

Webcast:

A live webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm or in the Corporate Highlights portion of the Investor Relations section of the Company's website at http://www.deltafinancial.com

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Artes Medical, Inc. (ARTE):

Artes Medical is a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for the dermatology and plastic surgery markets. There were approximately two million dermal filler procedures in the U.S. in 2006, an increase of 25% over the prior year, according to the American Society of Aesthetic Plastic Surgeons, or ASAPS. The Company's initial product, ArteFill(r), is being marketed to men and women as a treatment option for the correction of nasolabial folds. Additional information about Artes Medical and ArteFill is available at www.artesmedical.com and www.artefill.com.


Tags